Tanning lamps: health effects and reclassification by the Food and Drug Administration

Abstract

Tanning lamps have long been considered a class I medical device under regulation by the Food and Drug Administration (FDA). A growing body of research has repeatedly documented the association between elective indoor tanning and several negative health consequences. These accepted findings have prompted action by the FDA to officially reclassify tanning lamps as a class II medical device. The main purpose of this review is to update practitioners on the current state of tanning lamp classification and highlight the practical implications of this recent change. This information can be used by clinicians to easily reference this important action, and empower patients with a better understanding of the risks associated with indoor tanning.

Keywords: Food and Drug Administration; addiction; basal cell carcinoma; melanoma; reclassification; squamous cell carcinoma; sunlamps; tanning beds; ultraviolet.